Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuwellis Inc NUWE

Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms... see more

Recent & Breaking News (NDAQ:NUWE)

Nuwellis Provides More Children in Texas With Access to Its Unique Fluid Management Technology

GlobeNewswire May 13, 2021

Nuwellis, Inc. Announces 18 Percent Increase in Revenue for First Quarter 2021 Over Previous Year and Provides Company Update

GlobeNewswire May 11, 2021

Nuwellis, Inc. To Announce First Quarter 2021 Financial Results on May 11, 2021

GlobeNewswire April 29, 2021

CHF Solutions Expands Commercial Focus, Changes Name to Nuwellis

GlobeNewswire April 27, 2021

CHF Solutions Expands Access to Ultrafiltration Therapy for Pediatric Patients in Two Texas Hospitals

GlobeNewswire April 23, 2021

CHF Solutions Announces First Patient Enrolled in the ULTRA-Peds Registry

GlobeNewswire April 20, 2021

The Portability of Aquadex SmartFlow® from CHF Solutions Could Mean More Critically-Ill Patients Have Access to Life-Saving Ultrafiltration Therapy

GlobeNewswire April 8, 2021

CHF Solutions, Inc. Announces Closing of $20.9 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

GlobeNewswire March 19, 2021

CHF Solutions, Inc. Announces Pricing of $18.1 Million Underwritten Public Offering of Common Stock

GlobeNewswire March 17, 2021

CHF Solutions, Inc. Announces Proposed Underwritten Public Offering of Common Stock

GlobeNewswire March 16, 2021

CHF Solutions Submits Patent Application for New Peripheral Venous Access Technology for Ultrafiltration and CRRT Systems

GlobeNewswire March 11, 2021

CHF Solutions Expands Access to Ultrafiltration Therapy for Pediatric Patients in Puerto Rico

GlobeNewswire March 9, 2021

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire March 5, 2021

ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients

GlobeNewswire March 4, 2021

CHF Solutions, Inc. Announces 49.5 Percent Increase in Revenue for Fourth Quarter 2020 and Provides Company Update

GlobeNewswire March 2, 2021

CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021

GlobeNewswire February 16, 2021

CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability

GlobeNewswire February 3, 2021

CHF Solutions' Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients

GlobeNewswire January 28, 2021

CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients

GlobeNewswire January 21, 2021

CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer

GlobeNewswire January 19, 2021